Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
MASS Quote, Financials, Valuation and Earnings
Last price:
$6.77
Seasonality move
:
-19.35%
Day range:
$6.63 - $6.96
52-week range:
$1.81 - $8.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.84x
P/B ratio:
1.53x
Volume:
201K
Avg. volume:
609.9K
1-year change:
11.51%
Market cap:
$243.1M
Revenue:
$59.6M
EPS (TTM):
-$0.54
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $26.9M | $42.2M | $46.9M | $50.2M | $59.6M | |
| Revenue Growth (YoY) | 49.64% | 56.94% | 11.01% | 7.21% | 18.72% | |
| Cost of Revenues | $12M | $19M | $20.8M | $24.9M | $29.8M | |
| Gross Profit | $14.9M | $23.2M | $26M | $25.3M | $29.9M | |
| Gross Profit Margin | 55.49% | 55.05% | 55.54% | 50.41% | 50.07% | |
| R&D Expenses | $8.2M | $13.1M | $17.5M | $21.9M | $25.5M | |
| Selling, General & Admin | $12.5M | $32.2M | $43.9M | $46.1M | $53.6M | |
| Other Inc / (Exp) | -$6M | -$162K | -$83K | -$238K | -$27.7M | |
| Operating Expenses | $20.7M | $45.3M | $61.4M | $68M | $79.1M | |
| Operating Income | -$5.8M | -$22.1M | -$35.4M | -$42.7M | -$49.3M | |
| Net Interest Expenses | $976K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$12.8M | -$22.2M | -$33.6M | -$36.6M | -$72.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$211K | -$282K | |
| Net Income to Company | -$12.8M | -$22.2M | -$33.6M | -$36.4M | -$72.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.8M | -$22.2M | -$33.6M | -$36.4M | -$72.2M | |
| Basic EPS (Cont. Ops) | -$2.35 | -$0.79 | -$1.07 | -$1.13 | -$2.12 | |
| Diluted EPS (Cont. Ops) | -$2.35 | -$0.79 | -$1.07 | -$1.13 | -$2.12 | |
| Weighted Average Basic Share | $5.5M | $28M | $31.5M | $32.2M | $34.1M | |
| Weighted Average Diluted Share | $5.5M | $28M | $31.5M | $32.2M | $34.1M | |
| EBITDA | -$11M | -$20.8M | -$31.8M | -$34M | -$67.8M | |
| EBIT | -$11.8M | -$21.7M | -$33.4M | -$36.4M | -$72.5M | |
| Revenue (Reported) | $26.9M | $42.2M | $46.9M | $50.2M | $59.6M | |
| Operating Income (Reported) | -$5.8M | -$22.1M | -$35.4M | -$42.7M | -$49.3M | |
| Operating Income (Adjusted) | -$11.8M | -$21.7M | -$33.4M | -$36.4M | -$72.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5M | $8.3M | $9.5M | $7.4M | $11.8M | |
| Revenue Growth (YoY) | 38.54% | 49.85% | 14.22% | -21.77% | 58.68% | |
| Cost of Revenues | $2.6M | $4.2M | $5.1M | $3.5M | $6.2M | |
| Gross Profit | $2.9M | $4.1M | $4.4M | $3.9M | $5.5M | |
| Gross Profit Margin | 52.46% | 49.71% | 46.21% | 52.37% | 47.05% | |
| R&D Expenses | $3M | $3.9M | $5.4M | $3.3M | $3.8M | |
| Selling, General & Admin | $5.8M | $9.7M | $12M | $8.2M | $10.2M | |
| Other Inc / (Exp) | $91K | -$45K | $19K | -$13K | -$2.1M | |
| Operating Expenses | $8.7M | $13.7M | $17.4M | $11.5M | $14.1M | |
| Operating Income | -$5.8M | -$9.5M | -$13M | -$7.6M | -$8.5M | |
| Net Interest Expenses | $376K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.1M | -$9.4M | -$12.5M | -$5.9M | -$9.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$5M | $53.4M | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Basic EPS (Cont. Ops) | -$0.22 | -$0.30 | -$0.39 | -$0.33 | $1.23 | |
| Diluted EPS (Cont. Ops) | -$0.22 | -$0.30 | -$0.39 | -$0.33 | $1.23 | |
| Weighted Average Basic Share | $27.3M | $31.2M | $32M | $32.7M | $35.4M | |
| Weighted Average Diluted Share | $27.3M | $31.2M | $32M | $32.7M | $35.4M | |
| EBITDA | -$5.6M | -$9.1M | -$11.3M | -$6.3M | -$7.2M | |
| EBIT | -$5.7M | -$9.4M | -$12M | -$7.6M | -$8.5M | |
| Revenue (Reported) | $5.5M | $8.3M | $9.5M | $7.4M | $11.8M | |
| Operating Income (Reported) | -$5.8M | -$9.5M | -$13M | -$7.6M | -$8.5M | |
| Operating Income (Adjusted) | -$5.7M | -$9.4M | -$12M | -$7.6M | -$8.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.4M | $45M | $48M | $48.2M | $61.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.7M | $20.5M | $21.8M | $23.3M | $31M | |
| Gross Profit | $15.7M | $24.5M | $26.3M | $24.8M | $30.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9M | $14M | $19M | $19.8M | $23.5M | |
| Selling, General & Admin | $15.6M | $36.2M | $46.1M | $42.5M | $52M | |
| Other Inc / (Exp) | -$6M | -$298K | -$19K | $11K | -$29.8M | |
| Operating Expenses | $24.6M | $50.2M | $65.2M | $62.3M | $75.5M | |
| Operating Income | -$8.9M | -$25.8M | -$38.9M | -$37.5M | -$45.1M | |
| Net Interest Expenses | $1.1M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15.9M | -$25.5M | -$36.7M | -$29.9M | -$71.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$5M | $53.4M | |
| Income Tax Expense | -- | -- | -- | -$230K | -- | |
| Net Income to Company | -$15.9M | -$25.5M | -$36.7M | -$34.8M | -$17.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15.9M | -$25.5M | -$36.7M | -$34.8M | -$17.7M | |
| Basic EPS (Cont. Ops) | -$1.74 | -$0.88 | -$1.16 | -$1.07 | -$0.54 | |
| Diluted EPS (Cont. Ops) | -$1.74 | -$0.88 | -$1.16 | -$1.07 | -$0.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$14.1M | -$24.3M | -$34M | -$30.4M | -$65.4M | |
| EBIT | -$14.8M | -$25.4M | -$36M | -$33.4M | -$70M | |
| Revenue (Reported) | $28.4M | $45M | $48M | $48.2M | $61.4M | |
| Operating Income (Reported) | -$8.9M | -$25.8M | -$38.9M | -$37.5M | -$45.1M | |
| Operating Income (Adjusted) | -$14.8M | -$25.4M | -$36M | -$33.4M | -$70M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5M | $8.3M | $9.5M | $7.4M | $11.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6M | $4.2M | $5.1M | $3.5M | $6.2M | |
| Gross Profit | $2.9M | $4.1M | $4.4M | $3.9M | $5.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3M | $3.9M | $5.4M | $3.3M | $3.8M | |
| Selling, General & Admin | $5.8M | $9.7M | $12M | $8.2M | $10.2M | |
| Other Inc / (Exp) | $91K | -$45K | $19K | -$13K | -$2.1M | |
| Operating Expenses | $8.7M | $13.7M | $17.4M | $11.5M | $14.1M | |
| Operating Income | -$5.8M | -$9.5M | -$13M | -$7.6M | -$8.5M | |
| Net Interest Expenses | $376K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.1M | -$9.4M | -$12.5M | -$5.9M | -$9.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$5M | $53.4M | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Basic EPS (Cont. Ops) | -$0.22 | -$0.30 | -$0.39 | -$0.33 | $1.23 | |
| Diluted EPS (Cont. Ops) | -$0.22 | -$0.30 | -$0.39 | -$0.33 | $1.23 | |
| Weighted Average Basic Share | $27.3M | $31.2M | $32M | $32.7M | $35.4M | |
| Weighted Average Diluted Share | $27.3M | $31.2M | $32M | $32.7M | $35.4M | |
| EBITDA | -$5.6M | -$9.1M | -$11.3M | -$6.3M | -$7.2M | |
| EBIT | -$5.7M | -$9.4M | -$12M | -$7.6M | -$8.5M | |
| Revenue (Reported) | $5.5M | $8.3M | $9.5M | $7.4M | $11.8M | |
| Operating Income (Reported) | -$5.8M | -$9.5M | -$13M | -$7.6M | -$8.5M | |
| Operating Income (Adjusted) | -$5.7M | -$9.4M | -$12M | -$7.6M | -$8.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $159.2M | $224.1M | $188.4M | $121M | $44M | |
| Short Term Investments | -- | -- | -- | $24.6M | $25.6M | |
| Accounts Receivable, Net | $6.8M | $16.4M | $10M | $9M | $12.6M | |
| Inventory | $4.6M | $7.9M | $12.5M | $14.9M | $16.2M | |
| Prepaid Expenses | $347K | -- | -- | -- | -- | |
| Other Current Assets | -- | $4.5M | $4.7M | $4.2M | $4.7M | |
| Total Current Assets | $171M | $252.9M | $215.6M | $173.8M | $103.1M | |
| Property Plant And Equipment | $7.1M | $6.8M | $7M | $9.6M | $10.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $10.1M | $10.4M | -- | |
| Other Intangibles | -- | -- | $8.5M | $7.9M | $45.3M | |
| Other Long-Term Assets | $723K | $1.2M | $1.4M | $1.4M | $829K | |
| Total Assets | $178.8M | $260.9M | $242.6M | $203M | $159.5M | |
| Accounts Payable | $1M | $1.4M | $1.4M | $1.2M | $2.1M | |
| Accrued Expenses | $3M | $3.7M | $3.9M | $2.7M | $2.3M | |
| Current Portion Of Long-Term Debt | $500K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.2M | $1.3M | $1.5M | $2M | $1.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $10.8M | $14.8M | $19.2M | $22.5M | $25.1M | |
| Long-Term Debt | $14.3M | $15M | $15M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $39.8M | $46.3M | $52M | $37.5M | $44.9M | |
| Common Stock | $27K | $31K | $32K | $33K | $35K | |
| Other Common Equity Adj | -- | -- | $798K | $1.4M | $1.1M | |
| Common Equity | $139M | $214.6M | $190.6M | $165.5M | $114.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $139M | $214.6M | $190.6M | $165.5M | $114.6M | |
| Total Liabilities and Equity | $178.8M | $260.9M | $242.6M | $203M | $159.5M | |
| Cash and Short Terms | $159.2M | $224.1M | $188.4M | $145.7M | $69.6M | |
| Total Debt | $14.8M | $15M | $15M | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $149M | $223.1M | $161.2M | $104.6M | $79.2M | |
| Short Term Investments | -- | -- | -- | $29.6M | $45.2M | |
| Accounts Receivable, Net | $4.4M | $6.3M | $8.2M | $7.5M | $6.9M | |
| Inventory | $6.8M | $9.6M | $13.4M | $16.4M | $12.7M | |
| Prepaid Expenses | $2.7M | $3.9M | -- | -- | -- | |
| Other Current Assets | -- | -- | $5.2M | $3.8M | $5M | |
| Total Current Assets | $163M | $243M | $187.9M | $161.9M | $149M | |
| Property Plant And Equipment | $7M | $7.1M | $10.6M | $9M | $5.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $10.2M | $10.1M | -- | |
| Other Intangibles | -- | -- | $8.4M | $7.5M | $38M | |
| Other Long-Term Assets | $1.8M | $1.2M | $1.2M | $1.3M | $4M | |
| Total Assets | $171.8M | $251.2M | $218.4M | $189.8M | $196M | |
| Accounts Payable | $1.7M | $2.2M | $1.7M | $1.5M | $3.8M | |
| Accrued Expenses | $2.2M | $3M | $4.3M | $2.1M | $1.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.2M | $1.4M | $1.7M | $2.1M | $1.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $9.2M | $13.7M | $18.7M | $19.3M | $19.6M | |
| Long-Term Debt | $15M | $15M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.4M | $44.4M | $37.8M | $32.9M | $36.6M | |
| Common Stock | $27K | $31K | $32K | $33K | $36K | |
| Other Common Equity Adj | -- | -- | $1.1M | $980K | -$2K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $133.3M | $206.8M | $180.6M | $156.9M | $159.4M | |
| Total Liabilities and Equity | $171.8M | $251.2M | $218.4M | $189.8M | $196M | |
| Cash and Short Terms | $149M | $223.1M | $161.2M | $134.2M | $124.3M | |
| Total Debt | $15M | $15M | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.8M | -$22.2M | -$33.6M | -$36.4M | -$72.2M | |
| Depreciation & Amoritzation | $831K | $925K | $1.6M | $2.4M | $4.7M | |
| Stock-Based Compensation | $525K | $2.5M | $7.2M | $9.8M | $11.8M | |
| Change in Accounts Receivable | -$1.8M | -$11.3M | $5.9M | $680K | -$2.9M | |
| Change in Inventories | $223K | -$4.5M | -$5.5M | -$3.9M | -$1.7M | |
| Cash From Operations | $4.1M | -$29.1M | -$20.9M | -$25.1M | -$30.2M | |
| Capital Expenditures | $9K | $737K | $2M | $2M | $602K | |
| Cash Acquisitions | -- | -- | -$13.8M | -- | -$44.8M | |
| Cash From Investing | -$9K | -$737K | -$15.8M | -$26.4M | -$46.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.2M | $30M | $60M | -- | -- | |
| Long-Term Debt Repaid | -$2.2M | -$30M | -$60M | -$15M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.9M | -$879K | -$374K | -$1.9M | -$1.5M | |
| Cash From Financing | $137.2M | $94.7M | $1.2M | -$15.9M | -$376K | |
| Beginning Cash (CF) | $17.9M | $159.2M | $224.1M | $188.6M | $121.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $141.3M | $64.9M | -$35.6M | -$67.4M | -$76.9M | |
| Ending Cash (CF) | $159.2M | $224.1M | $188.6M | $121.2M | $44.2M | |
| Levered Free Cash Flow | $4.1M | -$29.8M | -$23M | -$27.1M | -$30.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Depreciation & Amoritzation | $137K | $267K | $634K | $1.3M | $1.3M | |
| Stock-Based Compensation | $339K | $1.3M | $2.2M | $2.6M | $2.4M | |
| Change in Accounts Receivable | $2.5M | $10.1M | $1.9M | $1.5M | $4.6M | |
| Change in Inventories | -$2.5M | -$2M | -$990K | -$1.7M | -$2.1M | |
| Cash From Operations | -$9.6M | -$466K | -$10.6M | -$9.4M | -$15M | |
| Capital Expenditures | $9K | $617K | $1.2M | $903K | $159K | |
| Cash Acquisitions | -- | -- | -- | -- | $69.9M | |
| Cash From Investing | -$9K | -$617K | -$1.2M | -$5.8M | $50.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | $15M | -- | -- | -- | |
| Long-Term Debt Repaid | -$15M | -$15M | -$15M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$593K | -$194K | -$469K | -$1.4M | -$201K | |
| Cash From Financing | -$566K | $130K | -$15.4M | -$1.3M | -$189K | |
| Beginning Cash (CF) | $159.2M | $224.1M | $188.6M | $121.2M | $44.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | $5K | -$10K | $27K | |
| Additions / Reductions | -$10.2M | -$953K | -$27.2M | -$16.4M | $35.1M | |
| Ending Cash (CF) | $149M | $223.2M | $161.4M | $104.8M | $79.3M | |
| Levered Free Cash Flow | -$9.6M | -$1.1M | -$11.8M | -$10.3M | -$15.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.9M | -$25.5M | -$36.7M | -$34.8M | -$17.7M | |
| Depreciation & Amoritzation | $763K | $1.1M | $2M | $3.1M | $4.6M | |
| Stock-Based Compensation | $798K | $3.5M | $8.1M | $10.3M | $11.5M | |
| Change in Accounts Receivable | -$55K | -$3.7M | -$2.2M | $267K | $225K | |
| Change in Inventories | -$1.2M | -$4M | -$4.5M | -$4.6M | -$2.1M | |
| Cash From Operations | -$2.3M | -$19.9M | -$31.1M | -$23.8M | -$35.9M | |
| Capital Expenditures | -$73K | $1.3M | $2.6M | $1.8M | -$142K | |
| Cash Acquisitions | -- | -- | -$13.8M | -- | $25.1M | |
| Cash From Investing | $73K | -$1.3M | -$16.4M | -$31M | $9.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $17.2M | $30M | -- | -- | -- | |
| Long-Term Debt Repaid | -$17.2M | -$30M | -$60M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$480K | -$649K | -$2.8M | -$367K | |
| Cash From Financing | $136.6M | $95.4M | -$14.3M | -$1.8M | $730K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $134.4M | $74.2M | -$61.8M | -$56.6M | -$25.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.3M | -$21.3M | -$33.7M | -$25.5M | -$35.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.1M | -$9.4M | -$12.5M | -$10.9M | $43.6M | |
| Depreciation & Amoritzation | $137K | $267K | $634K | $1.3M | $1.3M | |
| Stock-Based Compensation | $339K | $1.3M | $2.2M | $2.6M | $2.4M | |
| Change in Accounts Receivable | $2.5M | $10.1M | $1.9M | $1.5M | $4.6M | |
| Change in Inventories | -$2.5M | -$2M | -$990K | -$1.7M | -$2.1M | |
| Cash From Operations | -$9.6M | -$466K | -$10.6M | -$9.4M | -$15M | |
| Capital Expenditures | $9K | $617K | $1.2M | $903K | $159K | |
| Cash Acquisitions | -- | -- | -- | -- | $69.9M | |
| Cash From Investing | -$9K | -$617K | -$1.2M | -$5.8M | $50.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | $15M | -- | -- | -- | |
| Long-Term Debt Repaid | -$15M | -$15M | -$15M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$593K | -$194K | -$469K | -$1.4M | -$201K | |
| Cash From Financing | -$566K | $130K | -$15.4M | -$1.3M | -$189K | |
| Beginning Cash (CF) | $159.2M | $224.1M | $188.6M | $121.2M | $44.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | $5K | -$10K | $27K | |
| Additions / Reductions | -$10.2M | -$953K | -$27.2M | -$16.4M | $35.1M | |
| Ending Cash (CF) | $149M | $223.2M | $161.4M | $104.8M | $79.3M | |
| Levered Free Cash Flow | -$9.6M | -$1.1M | -$11.8M | -$10.3M | -$15.2M | |
Get MASS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MASS
Sector
P/E ratio
--
23.75x
PEG ratio
-0.03x
0.00x
P/B ratio
1.53x
2.35x
Price / LTM sales
3.84x
1.66x
Growth Metrics
MASS
Sector
Revenue growth
58.68%
3.91%
Earnings growth
--
11.1%
Revenue (5-year growth)
27.11%
6.27%
Earnings forecast
-$0.15
$0.12
Profitability
MASS
Sector
Profitability FY 2024
$29.9M
$76.5M
Return on invested capital
-12.31%
0.05%
Return on assets
-9.49%
-0.48%
Return on equity
-12.31%
0.73%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
12
Balance Sheet
MASS
Sector
Total cash
$124.3M
$48.7M
Short term investments
$25.6M
$19.4M
Total assets
$159.5M
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
